Publications and Presentations Database
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone..
Genetics in medicine : official journal of the American College of Medical Genetics. 20(1), 132-41. Abstract
(2018).
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial..
Annals of internal medicine. 164(3), 155-63. Abstract
(2016).
(2014).
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2009).
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2009).
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
Genetics in medicine : official journal of the American College of Medical Genetics. 10(3), 207-14. Abstract
(2008).
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study.
Genetics in medicine : official journal of the American College of Medical Genetics. 8(12), 746-51. Abstract
(2006).
Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.
Journal of geriatric psychiatry and neurology. 18(4), 250-5. Abstract
(2005).
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.
Genetics in medicine : official journal of the American College of Medical Genetics. 6(4), 197-203. Abstract
(2004).
Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease.
Alzheimer disease and associated disorders. 17(2), 86-93. Abstract
(2003).